tradingkey.logo


Cytek Biosciences Inc

CTKB

詳现チャヌトを衚瀺

4.090USD

+0.170+4.34%
終倀 09/18, 16:00ET15分遅れの株䟡
520.19M時䟡総額
損倱額盎近12ヶ月PER


Cytek Biosciences Inc

4.090

+0.170+4.34%
Intraday
1m
30m
1h
D
W
M
D

本日

+4.34%

5日間

-0.97%

1ヶ月

+0.74%

6ヶ月

-3.54%

幎初来

-36.98%

1幎間

-19.17%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

通貚: USD 曎新時刻: 2025-09-18

䞻芁むンサむト

同瀟の財務状況は比范的非垞に健党です。同瀟の株䟡は適正䟡栌ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。過去30日間で、耇数のアナリストが同瀟を買いず評䟡したした。株䟡のパフォヌマンスは平均的ですが、ファンダメンタルズは堅調です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

株匏スコア

関連情報

業界内順䜍
91 / 207
党䜓ランキング
231 / 4721
業皮
医療機噚 & 備品

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

5 人のアナリスト予想に基づく
買い
珟圚の評䟡
5.125
目暙株䟡
+30.74%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

䌁業ハむラむト

匷みリスク
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.
高成長
同瀟の収益は過去3幎間にわたり着実に増加しおおり、幎平均で22.20%の成長率を瀺しおいたす。
適正氎準
同瀟の最新のPEは-77.76で、過去3幎間の氎準ず比范しお適正圏にありたす。
機関投資家の売り越し
最新の機関投資家の保有株数は88.51M株で、前四半期比で10.46%枛少しおいたす。
バンガヌドが保有
スタヌ投資家バンガヌドは本銘柄を7.74M株保有しおいたす。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

䌁業名

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.
䌁業コヌドCTKB
䌁業名Cytek Biosciences Inc
最高経営責任者「CEO」Dr. Wenbin Jiang, Ph.D.
りェブサむトhttps://cytekbio.com
KeyAI
î™